ONCO (STOCKS)
Onconetix, Inc. Common Stock
$0.882400
-0.009200 (-1.03%)
Prev close: $0.891600
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Allan White
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3.84M
- Employees
- 5
- P/E (TTM)
- —
- P/B (TTM)
- 0.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q1)
|
$0.25 | $0.00 | +0.0000 | +0.00% |
|
Sep 2023 (Q3)
|
$-45,900.00 | $-32,946.00 | -12,954.0000 | -39.32% |
|
Jun 2023 (Q2)
|
$-35,700.00 | $-26,010.00 | -9,690.0000 | -37.25% |
|
Mar 2023 (Q1)
|
$-30,600.00 | $-36,414.00 | +5,814.0000 | +15.97% |
Financial Statements
| Revenues | $735.20K |
| Benefits Costs and Expenses | $10.44M |
| Cost Of Revenue | $149.77K |
| Costs And Expenses | -$4.38M |
| Gross Profit | $585.43K |
| Nonoperating Income/Loss | $5.81M |
| Operating Expenses | $16.10M |
| Selling, General, and Administrative Expenses | $7.41M |
| Depreciation and Amortization | $15.82K |
| Other Operating Expenses | $8.68M |
| Operating Income/Loss | -$15.51M |
| Income/Loss From Continuing Operations After Tax | -$9.70M |
| Income/Loss From Continuing Operations Before Tax | -$9.70M |
| Net Income/Loss | -$9.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.14 |
| Diluted Earnings Per Share | -$5.14 |
| Basic Average Shares | 2,811,904 |
| Diluted Average Shares | 2,811,904 |
| Assets | $14.83M |
| Current Assets | $4.33M |
| Inventory | $137.64K |
| Other Current Assets | $4.19M |
| Noncurrent Assets | $10.50M |
| Fixed Assets | $31.53K |
| Other Non-current Assets | $10.47M |
| Liabilities | $3.08M |
| Current Liabilities | $3.07M |
| Accounts Payable | $1.53M |
| Other Current Liabilities | $1.53M |
| Noncurrent Liabilities | $18.31K |
| Equity | $11.75M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.75M |
| Liabilities And Equity | $14.83M |
| Net Cash Flow From Operating Activities | -$9.80M |
| Net Cash Flow From Operating Activities, Continuing | -$9.80M |
| Net Cash Flow From Investing Activities | -$2.14M |
| Net Cash Flow From Investing Activities, Continuing | -$2.41M |
| Net Cash Flow From Financing Activities | $12.21M |
| Net Cash Flow From Financing Activities, Continuing | $12.21M |
| Exchange Gains/Losses | -$275.15K |
| Net Cash Flow | $275.15K |
| Net Cash Flow, Continuing | $550.30K |
| Comprehensive Income/Loss | -$9.42M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.19M |
| Other Comprehensive Income/Loss | -$7.04M |